During this webinar, Thomas Hanke, EVP Head of Academic Partnerships at Evotec in Germany, will present his vision and experience on how the preclinical validation of translational academic research projects should be planned and executed, in relationship with its foreseen clinical applications.
Evotec is a biotechnology company that offers technological expertise to advance drug discovery and development in a co-creation model with pharmaceutical companies, biotechs, foundations, and government agencies; as well as CRO/CDMO services for the Biopharma R&D sector.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Great atmosphere to learn and to share experiences.
Maria Ruiz Novales
Interface-Enterprises - University of Liege, Belgium
The software training filled in the many blanks and brought my 'fractioned' knowledge in a structured way. Very useful!
Ilse Sienaert
KU Leuven R&D, Belgium
It was great to experience the uncomplicated and fruitful exchange with colleagues from all over Europe, as well as the positive professional spirit of this conference.
Franck Döbrich
Universitat des Saarlandes WuT GmbH, Germany
Starting or changing any procedure at a TTO/Institution is challenging and I could not think of anything better than learning with the best.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Great networking and learning opportunities to share knowledge with colleagues from their various areas of expertise.
Bruno Woeran
Merinova OY - TII President, Finland
Join our newsletter and get the latest news